Home › Membranous Glomerulonephritis › Ohio
Membranous Glomerulonephritis clinical trials in Ohio
3 studies for Membranous Glomerulonephritis are looking for participants at sites in Ohio.
Cities in Ohio
Belimumab With Rituximab for Primary Membranous Nephropathy
- Cleveland Clinic, Cleveland
- Ohio State University Wexner Medical Center: Division of Nephrology, Columbus
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 18, 2026 · NCT03949855NEPTUNE Match Study
- Cleveland Clinic Foundation, Cleveland
Recruiting
Ages 1 to 80 · All sexes · Updated Jun 10, 2026 · NCT04571658Nephrotic Syndrome Study Network
- Cleveland Clinic, Cleveland
- The Ohio State University Wexner Medical Center, Columbus
RecruitingObservational study
Up to age 80 · All sexes · Updated Jun 10, 2026 · NCT01209000From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.